Article info
PDFLetter
Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment
- Correspondence to:
Dr Y El-Shabrawi
Department of Ophthalmology, Karl Franzens University Hospital, Auenbruggerplatz 4, 8036 Graz, Austria; yosuf.elshabrawikfunigraz.ac.at
Citation
Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment
Publication history
- Accepted August 4, 2003
- First published November 21, 2003.
Online issue publication
April 13, 2016
Copyright information
Copyright 2003 by Annals of the Rheumatic Diseases